Novo Nordisk A/S Common Stock (NVO)

Operating Cash Flow (Statement)

kr 55.20B

Quarterly · Period ending: · DKK

NVO logo

NVO Operating Cash Flow (Statement)

Latest reportedkr 55.20B DKK
NVO Quarterly Cash from Operations · DKK (kr 1.34B → kr 55.20B)
High-resolution chart · PNG

NVO operating cash flow (statement) history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Operating Cash Flow (Statement) — Quarterly (DKK)
Period endingOperating Cash Flow (Statement) (DKK)
55,199,000,000
24,084,000,000
7,619,000,000
46,107,000,000
40,785,000,000
24,591,000,000
12,301,000,000
43,850,000,000
50,503,000,000
14,314,000,000
9,551,000,000
40,966,000,000
28,577,000,000
29,814,000,000
7,101,000,000
24,239,000,000
23,961,000,000
23,586,000,000
-3,017,000,000
21,507,000,000
25,255,000,000
11,255,000,000
172,000,000
17,506,000,000
24,261,000,000
10,012,000,000
5,165,000,000
16,688,000,000
15,039,000,000
9,890,000,000
7,412,000,000
11,619,000,000
15,770,000,000
9,815,000,000
6,032,000,000
12,921,000,000
10,117,000,000
12,098,000,000
11,153,000,000
15,189,000,000
14,497,000,000
7,475,000,000
10,119,000,000
12,088,000,000
11,974,000,000
4,106,000,000
7,301,000,000
12,197,000,000
8,125,000,000
4,069,000,000
5,372,000,000
6,217,000,000
7,283,000,000
7,070,000,000
1,514,000,000
7,962,000,000
5,823,000,000
6,915,000,000
3,981,000,000
7,754,000,000
4,531,000,000
5,108,000,000
4,905,000,000
6,318,000,000
4,225,000,000
4,231,000,000
3,583,000,000
5,039,000,000
2,608,000,000
4,148,000,000
3,243,498,150
3,662,947,850
2,921,532,700
3,068,942,500
2,513,167,700
3,491,085,200
1,443,109,240
2,550,507,860
359,399,450
3,523,268,950
1,765,562,600
2,093,091,000
2,353,721,100
2,905,433,750
2,095,467,010
1,344,870,540
2,102,974,190
2,482,613,160
1,717,610,200
1,341,321,780
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.